Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Long

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Cancer Treatment Reports|August 1, 1986
Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatmentJ H Edmonson, J E Krook, J F Hilton, et al.
American Journal of Clinical Oncology|April 1, 1990
Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposureJ N Ingle, J E Krook, D J Schaid, et al.
Chronobiologia|July 11, 1992
Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacyG Cornélissen, F Halberg, E Halberg, et al.
American Journal of Clinical Oncology|June 1, 1991
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancerD L Ahmann, D J Schaid, J N Ingle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancerJ N Ingle, S J Green, D L Ahmann, et al.
Gynecologic Oncology|August 1, 1994
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinomaH J Long, R A Nelimark, J Q Su, et al.
Chronobiologia|January 1, 1992
Toward a chronotherapy of ovarian cancer with taxol. Part II: Test pilot study on circulating CA125E Halberg, H J Long, G Cornélissen, et al.
Cancer|September 15, 1994
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapyJ N Ingle, S A Kuross, J A Mailliard, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Gynecologic Oncology|August 1, 1995
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinomaH J Long, R M Langdon, S S Cha, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Cancer Treatment Reports|August 1, 1986
Ineffectiveness of tamoxifen in advanced endometrial carcinoma after failure of progestin treatmentJ H Edmonson, J E Krook, J F Hilton, et al.
American Journal of Clinical Oncology|April 1, 1990
Evaluation of trilostane plus hydrocortisone in women with metastatic breast cancer and prior hormonal therapy exposureJ N Ingle, J E Krook, D J Schaid, et al.
Chronobiologia|July 11, 1992
Toward a chronotherapy of ovarian cancer. Part III: Salivary CA125 for chronochemotherapy by efficacyG Cornélissen, F Halberg, E Halberg, et al.
American Journal of Clinical Oncology|June 1, 1991
A randomized trial of cyclophosphamide, doxorubicin, and prednisone versus cyclophosphamide, 5-fluorouracil, and prednisone in patients with metastatic breast cancerD L Ahmann, D J Schaid, J N Ingle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Randomized trial of tamoxifen alone or combined with aminoglutethimide and hydrocortisone in women with metastatic breast cancerJ N Ingle, S J Green, D L Ahmann, et al.
Gynecologic Oncology|August 1, 1994
Phase II evaluation of 5-fluorouracil and low-dose leucovorin in cisplatin-refractory advanced ovarian carcinomaH J Long, R A Nelimark, J Q Su, et al.
Chronobiologia|January 1, 1992
Toward a chronotherapy of ovarian cancer with taxol. Part II: Test pilot study on circulating CA125E Halberg, H J Long, G Cornélissen, et al.
Cancer|September 15, 1994
Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapyJ N Ingle, S A Kuross, J A Mailliard, et al.
Cancer|November 15, 1992
Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatinJ H Edmonson, L C Hartmann, H J Long, et al.
Gynecologic Oncology|August 1, 1995
Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent endometrial carcinomaH J Long, R M Langdon, S S Cha, et al.
Pageof 8